Page last updated: 2024-12-06
gyromitrin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
gyromitrin: isolated from edible mushroom Gyromitra (Helvella) esculenta; inhalation hallucinogen; highly toxic; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 9548611 |
CHEBI ID | 5583 |
SCHEMBL ID | 2932999 |
MeSH ID | M0047343 |
Synonyms (39)
Synonym |
---|
CHEBI:5583 |
acetaldehyde n-methyl-n-formylhydrazone |
n'-ethylidene-n-methylformohydrazide |
hydrazinecarboxaldehyde, ethylidenemethyl- |
acetaldehyde, n-formyl-n-methylhydrazone |
n-methyl-n-formylhydrazone acetaldehyde |
formic acid, ethylidenemethylhydrazide |
formic acid, 2-ethylidene-1-methylhydrazide |
wln: vhn1&nu2 |
acetaldehyde n-formyl-n-methylhydrazone |
nsc-240877 |
acetaldehyde n-methylformylhydrazone |
nsc240877 |
brn 1922396 |
hydrazine carboxyaldehyde, ethylidenemethyl- |
hydrazine carboxaldehyde, ethylidenemethyl- |
hsdb 3489 |
ethylidene gyromitrin |
ccris 5705 |
nsc 240877 |
gyromitrin |
C08305 |
16568-02-8 |
AKOS006279315 |
s9j72g0t46 , |
unii-s9j72g0t46 |
hydrazinecarboxaldehyde, ethylidenemethyl-, (e)- |
61748-21-8 |
gyromitrin [iarc] |
gyromitrin [hsdb] |
CCG-214846 |
IMAGWKUTFZRWSB-HWKANZROSA-N |
n'-[(e)-ethylidene]-n-methylformic hydrazide # |
formic acid, n'-ethylidene-n-methyl-hydrazide |
SCHEMBL2932999 |
n'-[(1e)-ethylidene]-n-methylformohydrazide |
DTXSID50872971 |
n-[(e)-ethylideneamino]-n-methylformamide |
BRD-K13037776-001-01-2 |
Research Excerpts
Dosage Studied
Excerpt | Relevance | Reference |
---|---|---|
" In mice exposed to MMH according to a dosing scheme identical to that reported to induce tumours in this species, O6-methylguanine was present in liver and kidney DNA." | ( Methylation of rat and mouse DNA by the mushroom poison gyromitrin and its metabolite monomethylhydrazine. Bergman, K; Hellenäs, KE, 1992) | 0.28 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (15)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 11 (73.33) | 18.7374 |
1990's | 1 (6.67) | 18.2507 |
2000's | 3 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (5.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 19 (95.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |